#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2414	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2464	289.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1685	1685	C	349	C	294	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2414	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2464	289.9	0	HET	.	.	.	A37T	.	37	37	A	538	538	A	386	A,T	262,77	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3870	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	290.9	0	.	n	.	0	T695C	SNP	695	695	T	1233	1233	C	305	C,G,A	253,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3870	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	290.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1875	1875	A	335	A,G	286,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3870	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	290.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2509	2509	C	402	C,T	341,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3870	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	290.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2583	2583	A	418	A	340	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3870	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	290.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3135	3135	C	303	C,T,A	130,126,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	416	folP	852	852	100.0	folP.l15.c4.ctg.1	1951	63.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1295	1297	AGC	93;94;94	A;G;C	78;80;80	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	812	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3829	63.7	1	SNP	p	S91F	0	.	.	271	273	TCC	771	773	TCC	76;76;76	T;C,A;C	62;60,1;63	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	812	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3829	63.7	1	SNP	p	D95G	0	.	.	283	285	GAC	783	785	GAC	71;70;70	G;A,T;C	61;59,1;59	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	812	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3829	63.7	1	SNP	p	D95N	0	.	.	283	285	GAC	783	785	GAC	71;70;70	G;A,T;C	61;59,1;59	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	316	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1782	53.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	641	643	ACC	87;87;87	A;C;C	75;75;76	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	316	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1782	53.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	656	658	CAC	90;90;91	C,A;A,C;C	76,1;75,1;78	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	316	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1782	53.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	839	841	CAC	77;77;77	C;A,T;C	72;73,1;73	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	316	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1782	53.3	1	SNP	p	G45D	0	.	.	133	135	GGC	659	661	GGC	91;91;91	G;G;C	77;77;77	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	250	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1379	53.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	810	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3205	75.0	1	SNP	p	D86N	0	.	.	256	258	GAC	657	659	GAC	81;79;79	G;A;C	70;65;69	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	810	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3205	75.0	1	SNP	p	S87I	0	.	.	259	261	AGT	660	662	AGT	79;79;78	A;G;T	70;68;71	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	810	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3205	75.0	1	SNP	p	S87R	0	.	.	259	261	AGT	660	662	AGT	79;79;78	A;G;T	70;68;71	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	810	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3205	75.0	1	SNP	p	S87W	0	.	.	259	261	AGT	660	662	AGT	79;79;78	A;G;T	70;68;71	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	810	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3205	75.0	1	SNP	p	S88P	0	.	.	262	264	TCC	663	665	TCC	78;78;78	T;C;C	67;68;68	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	654	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2962	65.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1682	1684	GGC	91;90;90	G;G;C	75;74;67	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1455	1457	GCA	85;85;85	G;C;A	68;69;69	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1458	1460	ATC	86;86;86	A;T,G;C	68;66,1;72	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1470	1472	GTG	85;85;85	G;T;G,T	67;67;67,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1470	1472	GTG	85;85;85	G;T;G,T	67;67;67,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1974	1976	ACC	68;68;68	A,C;C;C	54,1;56;58	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2028	2030	GCG	70;68;69	G;C;G	57;47;52	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2028	2030	GCG	70;68;69	G;C;G	57;47;52	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2151	2153	GGC	71;71;71	G;G,C;C,T	59;63,1;61,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2160	2162	GGC	73;73;73	G;G;C	62;63;60	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	566	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2913	58.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2178	2180	CCG	76;77;75	C;C;G	62;66;62	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	894	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3484	76.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	422	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2328	54.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	834	834	C	78	C	67	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	D41K	NONSYN	121	123	GAC	785	787	AAA	96;96;94	A;A;A	82;80;80	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	A109V	NONSYN	325	327	GCC	989	991	GTC	73;73;73	G;T;C	65;66;65	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	1055	1057	TAT	76;76;77	T,G;A;T	63,1;64;58	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	N134E	NONSYN	400	402	AAT	1064	1066	GAG	76;76;77	G;A,T;G	63;62,1;64	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	V135L	NONSYN	403	405	GTG	1067	1069	CTT	78;77;79	C;T;T	64;66;65	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	G140K	NONSYN	418	420	GGA	1082	1084	AAA	79;79;80	A;A;A	67;64;66	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	K143G	NONSYN	427	429	AAA	1091	1093	GGA	79;79;82	G;G;A	71;69;71	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1115	1117	GCA	79;80;80	G;C,A;A	68;66,1;69	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	D171G	NONSYN	511	513	GAC	1175	1177	GGT	76;76;76	G;G;T	67;65;67	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1223	1225	CGA	72;73;73	C,A;G;A	62,1;62;63	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	Y211_E212insL	INS	631	631	T	1295	1295	T	90	T	75	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1301	1303	GAT	88;87;87	G;A;T	74;73;71	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1304	1306	GAT	87;87;86	G;A;T	72;71;71	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	432	porB1b	1047	1047	96.01	porB1b.l15.c4.ctg.1	2048	62.4	0	.	p	.	0	Q214fs	FSHIFT	640	640	C	1307	1307	C	85	C	71	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1598	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5238	91.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2205	2207	AAT	92;92;91	A,C;A;T	82,1;80;80	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	270	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1349	59.7	1	SNP	p	V57M	1	.	.	169	171	ATG	642	644	ATG	119;119;118	A;T;G	96;97;98	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
